A Cell-Free Biosensor for Assessment of Hyperhomocysteinemia

ACS Synth Biol. 2023 Aug 18;12(8):2487-2492. doi: 10.1021/acssynbio.3c00103. Epub 2023 Jul 17.

Abstract

Hyperhomocysteinemia─a condition characterized by elevated levels of homocysteine in the blood─is associated with multiple health conditions including folate deficiency and birth defects, but there are no convenient, low-cost methods to measure homocysteine in plasma. A cell-free biosensor that harnesses the native homocysteine sensing machinery of Escherichia coli bacteria could satisfy the need for a detection platform with these characteristics. Here, we describe our efforts to engineer a cell-free biosensor for point-of-care, low-cost assessment of homocysteine status. This biosensor can detect physiologically relevant concentrations of homocysteine in plasma with a colorimetric output visible to the naked eye in under 1.5 h, making it a fast, convenient tool for point-of-use diagnosis and monitoring of hyperhomocysteinemia and related health conditions.

Keywords: cell-free biosensor; diagnostics; folate deficiency; homocysteine; hyperhomocysteinemia; monitoring.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Cross-Sectional Studies
  • Folic Acid
  • Folic Acid Deficiency*
  • Humans
  • Hyperhomocysteinemia* / diagnosis
  • Multimorbidity
  • Vitamin B 12

Substances

  • Folic Acid
  • Vitamin B 12